BL
BioLife Sciences Inc.
BLFE · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $156.7K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/FCF N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
33 /100
Unstable Profitable years 0
Beta -2,290.12x
EPS volatility N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BLFE
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Justin De Four
Employees
3
Headquarters
Henderson